Skip to main menu
Skip to content
Skip to main menu

Bio-Synergy Reasearch Center with Medicinal Heritage. Investigating how natural complex works 
within the human body Discovering new materials for future-shaping healthcare.

Introducing the Project

  • Backgrounds
  • Overview of the Project
  • Project Contents
  • Participating Organizations


Home > Introducing the Project > Backgrounds

Emerging Era of ‘Personalized Medicine’

  • Era of ‘personalized medicine’ which utilizes new technologies regarding genome, metabolites, and proteome has arrived, thanks to revolutionary BT and fusion of IT and NT.

    * It was declared, at the GET (Genomes, Environments, Traits) Conference held in April 2010, that the era of the Personal Genome has arrived after decoding more than 6 billion base codes of human DNA.

  • The U.S. government, as part of its healthcare policies, is continuing to provide incentives and financial support for the legislation of ‘personalized medicine’ and relevant researches.

Many countries are preparing strategies for the emergence of the ‘Aged society’

  • Furthermore, various aged-friendly technologies to predict and prevent senile diseases, enhance immune systems and mobility of the senile population, are continuing to be developed in many countries around the world.
  • In this context, technologies related to personalized medicine, disease-specific nutrition therapy, and prevention of aging-related chronic diseases, have emerged as new growth engines.

Botanical medicine has become a new leading paradigm for drug development.

  • Paradigms for new drug development have shifted to the goals of Predictive, Preventive, Personalized, and Participatory medicine.
  • Medicinal heritage, with its rich clinical experiences, has become substitutes for synthetic drugs by securing efficacy and safety.

    Ayurvedic medicine of India is one of the most successful examples of the reverse pharmacology, where new botanical drugs were developed through cross-national governmental projects.

    * The traditional medical system of Tibet and India, the Ayurveda, recorded more than 1,500 medicinal heritages and 10,000 prescriptions in detail.

  • Traditional Chinese Medicine, or TCM, has been integrated with modern drug discovery technology to investigate materials for new drugs and functional foods.

    * According to the reports from WHO, sales of drugs that have been developed out of Chinese medicinal heritage reached $14 billion in 2005, and $20 billion in 2010, in China.

Necessity of the Project

To construct national development plan based on public health

  • Early diagnosis and prevention of disease has become important in the upcoming medical environment; and the need has arisen to solve public healthcare problems due to the aging society and prevailing infectious diseases.
  • Newly developed biotechnology and cultivation of basis for pharmaceutics industry can contribute to enhancing national quality of life and economic development.
  • Due to Westernized food habits, health of people in their teens to 30s has significantly deteriorated. Governmental policy to enhance the public health is needed, therefore, giving each of the generations’ new hope.
    • Diseases influenced by food include cancer, infertility, obesity, diabetes, and atopic dermatitis, etc.
    • Frequency of cardiovascular and circulatory disease in people over 40s increased. (Cardiovascular disease is no. 1 cause of death for South Korean women population.)

To construct high-efficiency, low cost special support system for biological research

  • The support system will act as basis for enhancing research efficiency and shortening development duration of bio-pharmaceutical section.
  • The system will also help changing the overall landscape of the bio-industry by improving general levels of related pharmaceutical companies and researches by venture companies and universities (with close connection between large drug development R & Ds, and high-tech medical complexes)

To set more differentiated strategy than the advanced countries

  • In the USA, more than 2,900 drug candidates have been discovered in 2009 through various clinical trials with large support from R & D.

    Through the process, 750 new anti-cancer drugs, 312 cardioprotective agents, 150 anti-diabetic agents, 109 anti-AIDS agents, and 91 anti-Alzheimer and dementia agents have been discovered.

    * Source: Analysis reports from Pharmaceutical Research and Manufacturers of America (PhRMA) and Burrill & Co.